Monday, 04 March 2024


Australia's Starpharma names Justin Cahill as Chief Financial Officer and Company secretary

10 March 2023 | News

With more than 15 years’ experience in finance leadership roles, majority being in the healthcare and pharmaceutical sector

Australian firm Starpharma Holdings has announced the appointment of Justin Cahill as Chief Financial Officer (CFO) and Company Secretary, following an extensive executive search process.

Cahill has extensive corporate finance and leadership experience in the biopharmaceutical, food, and agricultural sectors for both ASX-listed and private companies. He is currently CFO at Paradigm Biopharmaceuticals having joined the company in 2020. During his time at Paradigm he has also worked closely with, and provided support to, the company secretarial function.

He also worked at CSL for over 9 years where he held a number of senior financial and leadership roles, including 5 years as Divisional CFO at CSL Plasma in the United States (US). As Divisional CFO, Cahill provided financial and strategic support to the organisation during a period of significant business expansion where the number of collection centres in the US increased from 65 to 130. He also led and contributed to a number of finance and operational initiatives which lowered operating costs and enabled organisational growth during this expansion period.

Cahill was later CSL’s Finance Integration Lead for the $250 million Novartis Influenza Acquisition in 2015. In this role, he led a team of finance staff spread across the US, Germany and Australia, to deliver all aspects of finance integration for the newly formed organisation, Seqirus.

Prior to joining Paradigm Biopharmaceuticals, Cahill was CFO at Diver Foods - Australia’s largest privately held manufacturer of cereal and muesli bars - where he was responsible for financial performance, as well as sourcing and supply chain.

 

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account